WC
TBRA

Wexford Capital’s Tobira Therapeutics, Inc. Common Stock TBRA Stock Holding History

Wexford Capital’s Portfolio TBRA Stock Details TBRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-22,222
Closed -$2.5M – 205
2014
Q1 		$2.5M Sell
22,222
-13,798
-38% -$969K 0.19% 81
2013
Q4 		$1.55M Sell
36,020
-3,579
-9% -$168K 0.13% 89
2013
Q3 		$2.38M Buy
+39,599
New +$2.08M 0.2% 70

Other funds holding TBRA

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIA
Biondo Investment Advisors Milford, Pennsylvania $780M AUM 21.03% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
SGAM
Smith Group Asset Management Dallas, Texas $1.96B AUM 43.61% 1-Year Est. Return

Wexford Capital's TBRA Position: Q2 2014 in Review

Wexford Capital sold out of Tobira Therapeutics, Inc. Common Stock (TBRA) in Q2 2014, closing a stake of 22,222 shares — an estimated $2.5M sold.

Wexford Capital first reported a position in TBRA in Q3 2013 and held it in 3 quarters. The position peaked at $2.5M in Q1 2014. 49 funds tracked by Wall St. Rank hold TBRA as of Q2 2014.

  • Wexford Capital reported no remaining Tobira Therapeutics, Inc. Common Stock position as of Q2 2014 after selling out during the quarter.
  • Wexford Capital sold 22,222 Tobira Therapeutics, Inc. Common Stock shares in Q2 2014, an estimated $2.5M.
  • Wexford Capital first reported a position in Tobira Therapeutics, Inc. Common Stock in Q3 2013 and held it in 3 quarters.
  • Wexford Capital's Tobira Therapeutics, Inc. Common Stock position peaked at $2.5M in Q1 2014.
  • 49 funds tracked by Wall St. Rank held Tobira Therapeutics, Inc. Common Stock as of Q2 2014.

Based on Wexford Capital's 13F filing for Q2 2014, filed 13 Aug 2014.